lidocaine spray in relieving pain caused by cervical biopsy through colposcopy

Determining the effectiveness of lidocaine spray in relieving pain caused by cervical biopsy through colposcopy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220606055087N1

Enrollment

Registered

2022-06-12

Start date

2022-08-11

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after biopsy. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group: In lithotomy position, after inserting a speculum, 4 puff of 10% concentration of lidocaine spray (each puff contains 10 mg of lidocaine) is sprayed in the vagin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with abnormal cervix screening test or colposcopy findings with biopsy indication

Exclusion criteria

Exclusion criteria: Lidocaine allergy Pregnancy Post-hysterectomy period

Design outcomes

Primary

Measure	Time frame
Pain after biopsy. Timepoint: Immediately after biopsy and 10 minutes after biopsy. Method of measurement: The Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ghomashi

Zanjan University of Medical Sciences

Z.ghomashi@yahoo.com+98 21 8806 4148

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026